NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Senti Biosciences

Senti Biosciences

Public
South San Francisco, CaliforniaBiotechhttps://www.sentibio.com

Last Round

Convertible Debt

Jun 4, 2026

Total Funding Raised

$279.38M

Company Overview

Senti Bio is a biotechnology company specializing in the development of next-generation cell and gene therapies using innovative gene circuit platform technologies to combat difficult diseases.

Sector

Biotech

AI Layer

Non-AI

Keywords

Gene Circuit platform for cell programmingoff-the-shelf CAR-NK cell therapylogic-gated CAR-NK cellssynthetic biology platform for therapeuticsengineered cell therapies for oncologymulti-antigen targeting cell therapyclinical-stage gene and cell therapyCAR-NK therapy for solid tumorsCAR-NK therapy for hematologic malignanciesbiotechnology R&D partnershipstherapeutic technology licensing

Senti Biosciences Comps

Public and private peers based on sector, stage, and business model.

Senti Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Senti Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtJun 4, 2026
PIPEDec 5, 2024
GrantJun 1, 2024
Reverse MergerJun 8, 2022
Convertible DebtMay 19, 2022
Series B
Jan 6, 2021

Senti Biosciences Investors

Notable investors and investment history

Senti Biosciences investors
InvestorRounds
MatrixSeries B
Allen & CompanySeries A
Smilegate InvestmentSeries B
Nest Bio VenturesSeries A, Series B
LifeSci Venture PartnersSeries B
KB InvestmentSeries B
Omega FundsSeries A

Senti Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Senti Biosciences Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range65
Year Founded2016
Last FundingJun 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.